{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:11:43Z","timestamp":1790881903816,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00223-009-9299-6","type":"journal-article","created":{"date-parts":[[2009,10,12]],"date-time":"2009-10-12T21:35:58Z","timestamp":1255383358000},"page":"484-493","source":"Crossref","is-referenced-by-count":85,"title":["Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)"],"prefix":"10.1007","volume":"85","author":[{"given":"Bente L.","family":"Langdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Rajzbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6sten","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Fahrleitner-Pammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bernard Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Kutahov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"9299_CR1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726\u20131733","journal-title":"Osteoporos Int"},{"key":"9299_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-003-1547-4","volume":"15","author":"W Cockerill","year":"2004","unstructured":"Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis JA, Kiss C, Masaryk P, Naves M, Poor G, Raspe H, Reid DM, Reeve J, Stepan J, Todd C, Woolf AD, O\u2019Neill TW (2004) Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15:113\u2013119","journal-title":"Osteoporos Int"},{"key":"9299_CR3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00198-007-0488-8","volume":"19","author":"C Cooper","year":"2008","unstructured":"Cooper C, Jakob F, Chinn C, Martin-Mola E, Fardellone P, Adami S, Thalassinos NC, Melo-Gomes J, Torgerson D, Gibson A, Marin F (2008) Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int 19:493\u2013501","journal-title":"Osteoporos Int"},{"key":"9299_CR4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761\u20131767","journal-title":"Lancet"},{"key":"9299_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229\u2013238","journal-title":"Osteoporos Int"},{"key":"9299_CR6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","volume":"359","author":"PD Delmas","year":"2002","unstructured":"Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018\u20132026","journal-title":"Lancet"},{"key":"9299_CR7","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010\u20132018","journal-title":"Lancet"},{"key":"9299_CR8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"9299_CR9","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R (2007) Teriparatide compared with alendronate for the treatment of glucocorticoid-induced osteoporosis. N Engl J Med 357:2028\u20132039","journal-title":"N Engl J Med"},{"key":"9299_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s001980070097","volume":"11","author":"R Dowd","year":"2000","unstructured":"Dowd R, Recker RR, Heaney RP (2000) Study subjects and ordinary patients. Osteoporos Int 11:533\u2013536","journal-title":"Osteoporos Int"},{"key":"9299_CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL (2009) From randomized controlled trials to observational studies. Am J Med 122:114\u2013120","journal-title":"Am J Med"},{"key":"9299_CR12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","volume":"21","author":"JA Cramer","year":"2005","unstructured":"Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21:1453\u20131460","journal-title":"Curr Med Res Opin"},{"key":"9299_CR13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"},{"key":"9299_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1185\/030079908X261087","volume":"24","author":"G Rajzbaum","year":"2007","unstructured":"Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Langdahl BL, Fahrleitner-Pammer A, Walsh JB, Gibson A, Tynan AJ, Marin F (2007) Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting. Curr Med Res Opin 24:377\u2013384","journal-title":"Curr Med Res Opin"},{"key":"9299_CR15","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1016\/S0002-9343(97)90025-5","volume":"103","author":"PD Ross","year":"1997","unstructured":"Ross PD (1997) Clinical consequences of vertebral fractures. Am J Med 103:30S\u201342S","journal-title":"Am J Med"},{"key":"9299_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group (1990) EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy 16:199\u2013208","journal-title":"Health Policy"},{"key":"9299_CR17","volume-title":"Measuring self-reported population health: an international perspective based on EQ-5D","year":"2004","unstructured":"Szende A, Williams A (eds) (2004) Measuring self-reported population health: an international perspective based on EQ-5D. SpringMed, Budapest"},{"key":"9299_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"YY Laing","year":"1986","unstructured":"Laing YY, Zeger SL (1986) Longitudinal data analysis using generalised linear models. Biometrika 73:13\u201322","journal-title":"Biometrika"},{"key":"9299_CR19","volume-title":"Applied logistic regression","year":"2000","unstructured":"Hosmer DW Jr, Lemershow S (eds) (2000) Applied logistic regression, 2nd edn. Wiley, New York","edition":"2"},{"key":"9299_CR20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00198-008-0766-0","volume":"20","author":"R Lindsay","year":"2009","unstructured":"Lindsay R, Miller P, Pohl G, Glass EV, Chen P, Krege JH (2009) Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis. Osteoporos Int 20:943\u2013948","journal-title":"Osteoporos Int"},{"key":"9299_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"9299_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"9299_CR23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320\u2013323","journal-title":"JAMA"},{"key":"9299_CR24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00198-007-0488-8","volume":"19","author":"C Cooper","year":"2008","unstructured":"Cooper C, Jakob F, Chinn C, Martin-Mola E, Fardellone P, Adami S, Thalassinos NC, Melo-Gomes J, Torgerson D, Gibson A, Marin F (2008) Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int 19:493\u2013501","journal-title":"Osteoporos Int"},{"key":"9299_CR25","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1210\/jc.2004-0826","volume":"90","author":"JC Gallagher","year":"2005","unstructured":"Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH (2005) Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab 90:1583\u20131587","journal-title":"J Clin Endocrinol Metab"},{"key":"9299_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00198-006-0230-y","volume":"18","author":"D Weycker","year":"2007","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2007) Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 18:271\u2013277","journal-title":"Osteoporos Int"},{"key":"9299_CR27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82:1493\u20131501","journal-title":"Mayo Clin Proc"},{"key":"9299_CR28","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00198-006-0171-5","volume":"17","author":"NK Arden","year":"2006","unstructured":"Arden NK, Earl S, Fisher DJ, Cooper C, Carruthers S, Goater M (2006) Persistence with teriparatide in patients with osteoporosis: the UK experience. Osteoporos Int 17:1626\u20131629","journal-title":"Osteoporos Int"},{"key":"9299_CR29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00198-008-0698-8","volume":"20","author":"K Briot","year":"2009","unstructured":"Briot K, Ravaud P, Dargent-Molina P, Zylberman M, Liu-Leage S, Roux C (2009) Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience. Osteoporos Int 20:625\u2013630","journal-title":"Osteoporos Int"},{"key":"9299_CR30","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.clinthera.2007.09.024","volume":"29","author":"JD Adachi","year":"2007","unstructured":"Adachi JD, Hanley DA, Lorraine JK, Yu M (2007) Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study. Clin Ther 29:2055\u20132069","journal-title":"Clin Ther"},{"key":"9299_CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","volume":"48","author":"J McCombs","year":"2004","unstructured":"McCombs J, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48:271\u2013287","journal-title":"Maturitas"},{"key":"9299_CR32","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","volume":"17","author":"D Weycker","year":"2006","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17:1645\u20131652","journal-title":"Osteoporos Int"},{"key":"9299_CR33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1185\/030079905X49671","volume":"21","author":"HK Genant","year":"2005","unstructured":"Genant HK, Halse J, Briney WG, Xie L, Glass EV, Krege JH (2005) The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr Med Res Opin 21:1027\u20131034","journal-title":"Curr Med Res Opin"},{"key":"9299_CR34","unstructured":"Ljunggren \u00d6, Fahrleitner-Pammer A, Kutahov A, Walsh JB, Langdahl B, Jakob F, Lems W, Rajzbaum G, Barker C, Karras D, Marin F (2008) Back pain is reduced in postmenopausal women with severe osteoporosis treated with rhPTH(1\u201334) (teriparatide) regardless of incident fractures: 18-month results from the European Forsteo Observational Study (EFOS). J Bone Miner Res 23:S347"},{"key":"9299_CR35","unstructured":"Langdahl B, Ljunggren \u00d6, Lems W, Walsh JB, Barker C, Fahrleitner-Pammer A, Karras D, Rajzbaum G, Jakob F, Kutahov A, Marin F (2008) Women with severe osteoporosis treated with rhPTH(1\u201334) (teriparatide) improve quality of life regardless of incident fractures: 18-month results from the European Forsteo Observational Study (EFOS). J Bone Miner Res 23:S347"},{"key":"9299_CR36","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00198-006-0177-z","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Kiel DP, Reginster JY, Dore RK, Zanchetta JR, Glass EV, Krege JH (2006) Reduction in the risk of developing back pain persists at least 30\u00a0months after discontinuation of teriparatide treatment: a meta-analysis. Osteoporos Int 17:1630\u20131637","journal-title":"Osteoporos Int"},{"key":"9299_CR37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-005-2013-2","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17:273\u2013280","journal-title":"Osteoporos Int"},{"key":"9299_CR38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00198-004-1744-9","volume":"16","author":"NM Schoor van","year":"2005","unstructured":"van Schoor NM, Smit JH, Twisk JWR, Lips P (2005) Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int 16:749\u2013756","journal-title":"Osteoporos Int"},{"key":"9299_CR39","first-page":"1579","volume":"30","author":"AK Oglesby","year":"2003","unstructured":"Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL (2003) The impact of incident vertebral and nonvertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women. J Rheumatol 30:1579\u20131583","journal-title":"J Rheumatol"},{"key":"9299_CR40","first-page":"1551","volume":"34","author":"F Salaffi","year":"2007","unstructured":"Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group (2007) The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34:1551\u20131560","journal-title":"J Rheumatol"},{"key":"9299_CR41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(09)60010-6","volume":"373","author":"D Wardlaw","year":"2009","unstructured":"Wardlaw D, Cummings SR, van Meirhaeghe J, Bastian L, Tillman TB, Ranstam J, Eastell R, Shabe P, Talmadge K, Boonen S (2009) Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 373:1016\u20131024","journal-title":"Lancet"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9299-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T07:07:40Z","timestamp":1554620860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-009-9299-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,13]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9299"],"URL":"https:\/\/doi.org\/10.1007\/s00223-009-9299-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,13]]}}}